131 related articles for article (PubMed ID: 17725302)
1. [Diffusion weighted imaging: its diagnostic and differential value for prostate cancer].
Shi H; Ding HY
Zhonghua Nan Ke Xue; 2007 Jul; 13(7):605-9. PubMed ID: 17725302
[TBL] [Abstract][Full Text] [Related]
2. Diffusion-weighted imaging in normal prostate and differential diagnosis of prostate diseases.
Ren J; Huan Y; Wang H; Zhao H; Ge Y; Chang Y; Liu Y
Abdom Imaging; 2008; 33(6):724-8. PubMed ID: 18219519
[TBL] [Abstract][Full Text] [Related]
3. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissue using thin-slice echo-planar imaging.
Manenti G; Squillaci E; Di Roma M; Carlani M; Mancino S; Simonetti G
Radiol Med; 2006 Dec; 111(8):1124-33. PubMed ID: 17171522
[TBL] [Abstract][Full Text] [Related]
4. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.
Kim CK; Park BK; Lee HM; Kwon GY
Invest Radiol; 2007 Dec; 42(12):842-7. PubMed ID: 18007156
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
7. Apparent diffusion coefficient: prostate cancer versus noncancerous tissue according to anatomical region.
Kim JH; Kim JK; Park BW; Kim N; Cho KS
J Magn Reson Imaging; 2008 Nov; 28(5):1173-9. PubMed ID: 18837000
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted imaging of the prostate at 3 T for differentiation of malignant and benign tissue in transition and peripheral zones: preliminary results.
Kim CK; Park BK; Han JJ; Kang TW; Lee HM
J Comput Assist Tomogr; 2007; 31(3):449-54. PubMed ID: 17538295
[TBL] [Abstract][Full Text] [Related]
9. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue.
Hosseinzadeh K; Schwarz SD
J Magn Reson Imaging; 2004 Oct; 20(4):654-61. PubMed ID: 15390142
[TBL] [Abstract][Full Text] [Related]
10. Diffusion-weighted imaging of normal and malignant prostate tissue at 3.0T.
Pickles MD; Gibbs P; Sreenivas M; Turnbull LW
J Magn Reson Imaging; 2006 Feb; 23(2):130-4. PubMed ID: 16374882
[TBL] [Abstract][Full Text] [Related]
11. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging.
Issa B
J Magn Reson Imaging; 2002 Aug; 16(2):196-200. PubMed ID: 12203768
[TBL] [Abstract][Full Text] [Related]
12. Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade.
Tamada T; Sone T; Jo Y; Toshimitsu S; Yamashita T; Yamamoto A; Tanimoto D; Ito K
J Magn Reson Imaging; 2008 Sep; 28(3):720-6. PubMed ID: 18777532
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection.
Morgan VA; Kyriazi S; Ashley SE; DeSouza NM
Acta Radiol; 2007 Jul; 48(6):695-703. PubMed ID: 17611881
[TBL] [Abstract][Full Text] [Related]
14. ADC value and diffusion tensor imaging of prostate cancer: changes in carbon-ion radiotherapy.
Takayama Y; Kishimoto R; Hanaoka S; Nonaka H; Kandatsu S; Tsuji H; Tsujii H; Ikehira H; Obata T
J Magn Reson Imaging; 2008 Jun; 27(6):1331-5. PubMed ID: 18504751
[TBL] [Abstract][Full Text] [Related]
15. Diffusion tensor magnetic resonance imaging of prostate cancer.
Manenti G; Carlani M; Mancino S; Colangelo V; Di Roma M; Squillaci E; Simonetti G
Invest Radiol; 2007 Jun; 42(6):412-9. PubMed ID: 17507813
[TBL] [Abstract][Full Text] [Related]
16. Correlation between metabolite ratios and ADC values of prostate in men with increased PSA level.
Kumar V; Jagannathan NR; Kumar R; Das SC; Jindal L; Thulkar S; Gupta SD; Dwivedi SN; Roell S; Hemal AK; Gupta NP
Magn Reson Imaging; 2006 Jun; 24(5):541-8. PubMed ID: 16735174
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of diffusion-weighted MRI with STIR-EPI in differential diagnosis of cervical lymph nodes].
Zhang Y; Liang BL; Gao L; Zhong JL; Ye RX; Shen J
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):70-3. PubMed ID: 17575700
[TBL] [Abstract][Full Text] [Related]
18. Age-related and zonal anatomical changes of apparent diffusion coefficient values in normal human prostatic tissues.
Tamada T; Sone T; Toshimitsu S; Imai S; Jo Y; Yoshida K; Yamamoto A; Yamashita T; Egashira N; Nagai K; Fukunaga M
J Magn Reson Imaging; 2008 Mar; 27(3):552-6. PubMed ID: 18219616
[TBL] [Abstract][Full Text] [Related]
19. Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer.
Zelhof B; Pickles M; Liney G; Gibbs P; Rodrigues G; Kraus S; Turnbull L
BJU Int; 2009 Apr; 103(7):883-8. PubMed ID: 19007373
[TBL] [Abstract][Full Text] [Related]
20. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy.
Kurhanewicz J; Vigneron DB; Nelson SJ; Hricak H; MacDonald JM; Konety B; Narayan P
Urology; 1995 Mar; 45(3):459-66. PubMed ID: 7533458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
